Management of medically refractory ascites

American Journal of Surgery

Volumn 181, Issue 3, 2001, Pages 256-264

  Zervos, Emmanuel E ^a   Rosemurgy, Alexander S ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Ascites; Large volume paracentesis; Peritoneovenous shunt; Transjugular intrahepatic portosystemic shunts

Indexed keywords

ANTIINFECTIVE AGENT; DIURETIC AGENT;

ALGORITHM; ASCITES; DECISION MAKING; DIURESIS; HUMAN; LIVER TRANSPLANTATION; PALLIATIVE THERAPY; PARACENTESIS; PATHOPHYSIOLOGY; PERITONEUM VEIN SHUNT; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SODIUM RESTRICTION; TREATMENT INDICATION;

EID: 0035270786     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(01)00565-7     Document Type: Article

References (74)

1. Silverberg E., Lubera J. Cancer statistics, 1987. CA Cancer J Clin. 37:1987;2-19.
2. Runyon B. Care of patients with ascites. N Engl J Med. 330:1994;337-342.
3. Gatta A., Angeli P., Caregaro L., et al. A pathophysiologic interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in non-azotemic cirrhotic patients. Hepatology. 14:1991;231-236.
4. Forns X., Gines A., Gines P., et al. Management of ascites and renal failure in cirrhosis. Semin Liver Dis. 14:1994;82-96.
5. Arroyo V., Gines P., Gerbes A., et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology. 23:1996;164-175.
6. Porayko M.K., Wiesner R.H. Management of ascites in patients with cirrhosis. Postgrad Med. 1992;92-166.
7. Roberts L., Kamath P. Ascites and hepatorenal syndrome pathophysiology and management . Mayo Clin Proc. 71:1996;874-881.
8. Dudley F.J. Pathophysiology of ascites formation. Gastroenterol Clin North Am. 21:1992;215-235.
9. Neuhaus P., Bechstein W.O. Ascites and liver transplantation. Chirurg. 64:1993;16-20.
10. Starzl TE, Demetris AJ, VanThiel D. Liver transplantation. N Engl J Med 1989;321:1014-1022,1092-9.
11. Gordon R.D., Todo S., Starzl T., et al. Liver transplantation under cyclosporine a decade of experience . Transplant Proc. 23:1991;1393l.
12. Franco D., Vons C., Traynor O., et al. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis. Arch Surg. 123:1988;987-991.
13. Elcheroth J., Vons C., Franco D. Role of surgical therapy in management of intractable ascites. World J Surg. 18:1994;240-245.
14. Castells A., Salo J., Planas R., et al. Impact of shunt surgery for variceal bleeding in the natural history of ascites in cirrhosis a retrospective study . Hepatology. 20:1994;584-591.
15. Burchell A.R., Rousselot L.M., Panke W.F. A seven-year experience with side-to-side portocaval shunt for cirrhotic ascites. Ann Surg. 168:1968;655-670.
16. Barker H.G., Reemtsma K. The portocaval operation in patients with cirrhosis and ascites. Surgery. 48:1960;142-150.
17. Welch H.F., Welch C.S., Carter J.H. Prognosis after surgical treatment of ascites results of side to side portocaval shunt in 40 patients . Surgery. 56:1964;75-80.
18. Orloff MJ. Surgical treatment of intractable cirrhotic ascites. Curr Probl Surg 1966 Jul:28-51.
19. Rosemurgy A.S., Serafini F.M., Zervos E.E., Goode S.E. Small-diameter prosthetic H-graft portocaval shunt definitive therapy for variceal bleeding . J Gastro Surg. 2:1998;585-591.
20. Rosemurgy A.S., Goode S.E., Zwiebel B.R., et al. A prospective trial of transjugular intrahepatic portosystemic stent shunts versus small diameter prosthetic H-graft portacaval shunts in the treatment of bleeding varices. Ann Surg. 224:1996;378-386.
21. Ochs A., Rossle M., Haag K., et al. The transjugular intrahepatic portosystemic stent shunt procedure for refractory ascites. N Engl J Med. 332:1995;1192-1197.
22. Quiroga J., Sangro B., Nunez M., et al. Transjugular intrahepatic portal-systemic shunt in the treatment of refractory ascites effect on clinical, renal, humoral, and hemodynamic parameters . Hepatology. 21:1995;986-994.
23. Ferral H., Bjarnason H., Wegryn S., et al. Refractory ascites early experience in treatment with transjugular intrahepatic portosystemic shunt . Radiology. 189:1993;795-801.
24. Nazarian G.K., Bjarnason H., Dietz C.A., et al. Refractory ascites midterm results of treatment with transjugular intrahepatic portosystemic shunt . Radiology. 205:1997;173-180.
25. Martinet J.P., Fenyves D., Legault L., et al. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS) a caution . Dig Dis Sci. 42:1997;161-166.
26. Rees C.J., Rose J.D., Record C.O., et al. Transjugular intrahepatic portosystemic shunt a limited role in refractory ascites . Eur J Gastroenterol Hepatol. 9:1997;969-973.
27. Williams D.B., Waugh R., Selby W. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites. Aust NZ J Med. 28:1998;620-626.
28. Deschenes M., Dufresne M.P., Bui B., et al. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites. Am J Gastroenterol. 94:1999;1361-1365.
29. Papatheodorakis G.V., Goulis J., Leandros G., et al. TIPS compared to endoscopic treatment for prevention of variceal rebleed a meta-analysis . Hepatology. 30:1999;612-622.
30. Williams D., Waugh R., Gallagher N., et al. Mortality and rebleeding following TIPS for variceal hemorrhage. J Gastroenterol Hepatol. 13:1998;163-169.
31. Sahagun G., Benner K.G., Saxon R., et al. Outcome of one hundred patients after TIPS for variceal hemorrhage. Am J Gastroenterol. 92:1997;1444-1452.
32. Zervos E.E., Rosemurgy A.S. Small diameter H-graft portacaval shunt versus TIPS for portal hypertension. Cameron J., Advances in surgery. 1997;105-126 Mosby, St. Louis.
33. Rosemurgy A.S., Zervos E.E., Goode S.E., Black T.J., Zwiebel B.R. Differential effects on portal and effective hepatic blood flow a comparison between TIPS and small diameter H-graft portacaval shunt . Ann Surg. 225:1997;601-608.
34. Zervos E.E., Goode S.E., Wright T., Rosemurgy A.S. A prospective randomized trial comparing TIPS and peritoneovenous shunt in the treatment of intractable ascites. Gastroenterology. 110:1996;A1368.
35. Fulenwider J.T., Galambos J.D., Smith R.B., et al. Leveen versus Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized prospective trial. Arch Surg. 121:1986;351-355.
36. Leveen H.H., Christoudias G., Ip M., et al. Peritoneovenous shunt for ascites. Ann Surg. 180:1974;580-591.
37. Moskovitz M. The peritoneovenous shunt expectations and reality . Am J Gastroenterol. 85:1990;917-929.
38. Blendis L.M., Greig P.D., Langer B., et al. Renal and hemodynamic function of peritoneovenous shunt for intractable hepatic ascites. Gastroenterology. 77:1979;250-257.
39. Vons C., Hadengue A., Lee S., et al. Splanchnic and systemic hemodynamics in cirrhotic patients with refractory ascites effect of peritoneovenous shunting . Hepato Pancreat Bil Surg. 3:1991;259-264.
40. Stanley M., Ochi S., Lee K., et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. N Engl J Med. 321:1989;1632-1638.
41. Gines P., Arroyo V., Vargas V., et al. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites. N Engl J Med. 325:1991;829-835.
42. Zervos E.E., McCormick J., Goode S.E., Rosemurgy A.S. Peritoneovenous shunts in patients with intractable ascites palliation at what price? Am Surg. 63:1997;157-162.
43. Fulenwider J.T., Smith R.B., Redd S.C., et al. Peritoneovenous shunt lessons learned from an 8 year experience with 70 patients . Arch Surg. 119:1984;1133-1137.
44. Tawes R.L., Sydorak G.R., Kennedy P.A., et al. Coagulopathy associated with peritoneovenous shunting. Surgery. 142:1981;51-55.
45. Rubinstein D., McInnes I., Dudley F. Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites. Gut. 26:1985;1070-1073.
46. Schwartz M.L., Swain W.R., Vogel S.B. Coagulopathy following peritoneovenous shunting. Surgery. 85:1979;6712-6716.
47. Biagini J.R., Belghiti J., Fekete F. Prevention of coagulopathy after placement of peritoneouvenous shunt with replacement of ascitic fluid by normal saline solution. Surg Gynecol Obstet. 163:1986;313-318.
48. Cambria R.P., Shamberger R.C. Small bowel obstruction caused by abdominal cocoon syndrome possible association with Leveen shunt . Surgery. 95:1984;501-503.
49. Stanley M., Reyes C.V., Greenlee H.B., et al. Peritoneal fibrosis in cirrhotics treated with peritoneovenous shunt for ascites an autopsy study and clinical correlation . Dig Dis Sci. 41:1996;571-577.
50. Gines P., Arroyo V., Quintero E., et al. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 93:1987;234-241.
51. Henderson J.M., Kutner M.H., Bain R.P. First order clearance of plasma galactose the effect of liver disease . Gastroenterology. 83:1982;1090-1098.
52. Henderson J.M., Fales F.W. Continuous flow fluorometry of low galactose concentrations in blood and plasma. Clin Chem. 26:1980;282-285.
53. Soper N.J., Rikker L.F., Davis E.K. Hepatic blood flow measurement comparison of indocyanine green and low dose galactose clearance techniques . Curr Surg. 41:1984;455-457.
54. Pugh R.N., Murray-Lyon I.M., Dawson M.C., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 60:1973;646-648.
55. Runyon B.A., Antillon M.R., Akriviadis E.A., et al. The serum-ascites albumin gradient is superior to the exudate/transudate concept in the differential diagnosis of ascites. Ann Intern Med. 117:1992;215-220.
56. Somberg K.A., Lombardero M.S., Lawlor S.M. Impact of TIPS on liver transplantation a controlled analysis . Transplant Proc. 27:1995;1248-1249.
57. Menegaux F., Baker E., Keeffe E.B., et al. Impact of TIPS on orthotopic liver transplantation. World J Surg. 18:1994;866-870.
58. Menegaux F., Keeffe E., Baker E., et al. Comparison of TIPS and surgical shunt on the outcome of liver transplantation. Arch Surg. 129:1994;1018-1023.
59. Holm-Nielson P. Pathogenesis of ascites in peritoneal carcinomatosis. APMIS. 33:1953;10-21.
60. Ringenberg Q.S., Doll D.C., Loy T.S., et al. Malignant ascites of unknown origin. Cancer. 32:1989;37-45.
61. Scholmerich J., Zimmerman U., Kottgen E., et al. Fibronectin concentration in ascites differentiates between malignant and non-malignant ascites. Gastroenterology. 87:1984;1160-1164.
62. Markman M. Intraperitoneal chemotherapy as a treatment of ovarian cancer why, how and when . Obstet Gynecol Surg. 42:1987;533-539.
63. Cunliffe W.J., Sugarbaker P.H. GI malignancy rationale for adjuvant treatment using early post-operative intraperitoneal chemotherapy . Br J Surg. 76:1989;1082-1090.
64. Parsons S.L., Watson S.A., Steele R.J.C. Malignant ascites. Br J Surg. 83:1996;6-14.
65. Faught W., Kirkpatirck J.R., Krepart G.V., et al. Peritoneovenous shunt for palliation of gynecologic malignant ascites. J Am Coll Surg. 180:1995;472-474.
66. Edney J.A., Hill A., Armstrong D. Peritoneovenous shunts palliate malignant ascites. Am J Surg. 158:1989;598-601.
67. Fletcher W.S., Lakin P.C., Powmier R.F., et al. Results of treatment of IVC syndrome with expandable metallic stents. Arch Surg. 133:1998;935-938.
68. Pockros P.J., Esrason K.T., Nguyen C., et al. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology. 103:1992;1302-1306.
69. Gough I.R. Control of malignant ascites by peritoneovenous shunts. Cancer. 54:1984;2226-2230.
70. Helzberg J.H., Greenberger N.J. Peritoneovenous shunts in malignant ascites. Dig Dis Sci. 30:1985;1104-1107.
71. Qazi R., Savlov E.D. Peritoneovenous shunt for palliation of malignant ascites. Cancer. 49:1982;600-602.
72. Tarin D., Price J.E., Kettlewell M.G., et al. Clinicopathological observations on metastases in man studied in patients with peritoneovenous shunts. Br Med J Clin Res. 288:1984;749-751.
73. Souter R.G., Tarin D., Kettlewell M.G. Peritoneovenous shunts in the management of malignant ascites. Br J Surg. 70:1983;478-481.
74. Straus A.K., Roseman D.L., Shapiro T.M. Peritoneovenous shunt in the management of malignant ascites. Arch Surg. 114:1979;489-491.